Arvinas has managed to secure another big pharma collaboration, after it announced that Pfizer had signed a research and licensing agreement. The deal adds to previous agreements signed with MSD and Genentech, cementing pharma’s interest in the biotech’s research area.
Ook interessant voor je
Reageer